Compared to Estimates, Imax (IMAX) Q3 Earnings: A Look at Key Metrics

23.10.25 17:00 Uhr

Werte in diesem Artikel
Aktien

27,60 EUR 0,20 EUR 0,73%

Indizes

23.827,5 PKT 190,0 PKT 0,80%

Imax (IMAX) reported $106.65 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 16.6%. EPS of $0.47 for the same period compares to $0.35 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $103.39 million, representing a surprise of +3.16%. The company delivered an EPS surprise of +23.68%, with the consensus EPS estimate being $0.38.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Imax performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total Commercial Multiplex Systems (Period End): 1,759 versus 1,763 estimated by three analysts on average.Total IMAX System installations: 38 versus 39 estimated by three analysts on average.Total Commercial Multiplex Systems (Period End) - International Total: 1,335 versus the two-analyst average estimate of 1,341.Total Commercial Multiplex Systems (Period End) - Domestic Total (United States & Canada): 424 versus the two-analyst average estimate of 420.Revenues- All other: $1.4 million compared to the $2.2 million average estimate based on seven analysts. The reported number represents a change of -58.2% year over year.Revenues- Technology Products and Services: $60.42 million versus the seven-analyst average estimate of $59.66 million. The reported number represents a year-over-year change of +4.2%.Revenues- Content Solutions: $44.83 million versus $41.53 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +48.8% change.Revenues- Technology Products and Services Revenue- Maintenance: $15.78 million versus the five-analyst average estimate of $15.97 million. The reported number represents a year-over-year change of +2.2%.Revenues- Technology Products and Services Revenue- Finance Income: $2.93 million versus the five-analyst average estimate of $2.52 million. The reported number represents a year-over-year change of +37.3%.Revenues- Technology Products and Services Revenue- System Rentals: $23.05 million versus the five-analyst average estimate of $22.85 million. The reported number represents a year-over-year change of +43.8%.Revenues- Content Solutions Revenue- Other Content Solutions: $2.92 million versus $2.45 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -15.2% change.Revenues- Content Solutions Revenue- Film Remastering and Distribution: $41.91 million versus the five-analyst average estimate of $41.26 million. The reported number represents a year-over-year change of +57.1%.View all Key Company Metrics for Imax here>>>Shares of Imax have returned -0.7% over the past month versus the Zacks S&P 500 composite's +0.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IMAX Corporation (IMAX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf IMAX

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf IMAX

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu IMAX Corp.

Wer­bung

Analysen zu IMAX Corp.

DatumRatingAnalyst
25.02.2019IMAX HoldCanaccord Adams
27.04.2018IMAX BuyThe Benchmark Company
28.02.2018IMAX BuyB. Riley FBR, Inc.
30.10.2017IMAX OutperformBarrington Research
12.07.2017IMAX Mkt PerformBarrington Research
DatumRatingAnalyst
27.04.2018IMAX BuyThe Benchmark Company
28.02.2018IMAX BuyB. Riley FBR, Inc.
30.10.2017IMAX OutperformBarrington Research
21.04.2017IMAX OutperformWedbush Morgan Securities Inc.
22.04.2016IMAX BuyMKM Partners
DatumRatingAnalyst
25.02.2019IMAX HoldCanaccord Adams
12.07.2017IMAX Mkt PerformBarrington Research
07.06.2017IMAX HoldThe Benchmark Company
03.05.2011IMAX holdStifel, Nicolaus & Co., Inc.
12.01.2006IMAX abwartenDer Aktionär
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IMAX Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen